Opus Genetics IRD Unrealized Gain (Loss) on Investments
Unrealized Gain (Loss) on Investments at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's unrealized gain (loss) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's unrealized gain (loss) on investments?
- Opus Genetics (IRD) reported unrealized gain (loss) on investments of $0 in Q1 2026.
- How has Opus Genetics's unrealized gain (loss) on investments changed year-over-year?
- Opus Genetics's unrealized gain (loss) on investments increased by 100.0% year-over-year, from -$1K to $0.
- What is the long-term trend for Opus Genetics's unrealized gain (loss) on investments?
- Over 2 years (2021 to 2024), Opus Genetics's unrealized gain (loss) on investments has grown at a -56.9% compound annual growth rate (CAGR), from -$70K to -$13K.
- What does unrealized gain (loss) on investments mean?
- The change in the fair market value of investment holdings that have not yet been sold. This reflects the volatility of the company's investment portfolio and its impact on the balance sheet and comprehensive income.